﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Wed, 06 May 2026 13:07:32 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/August-2020/rss/2172</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/August-2020/rss/2172" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Inpatient Insights]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/inpatient-insights-39</link><description><![CDATA[ Inappropriate medications at discharge could lead to adverse effects 

   

 While admission to hospital provides an opportunity for a comprehensive medication review, the safety of drug ...]]></description><pubDate>Tue, 07 Jul 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/inpatient-insights-39</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2813]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Dapagliflozin approved as new heart failure treatment]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dapagliflozin-approved-as-new-heart-failure-treatment</link><description><![CDATA[  Joey Sweeney, PharmD, BCPS  

   

 In May, FDA approved dapagliflozin to treat patients with New York Heart Association (NYHA) class II–IV heart failure with reduced ejection fraction to ...]]></description><pubDate>Tue, 07 Jul 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dapagliflozin-approved-as-new-heart-failure-treatment</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2810]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Considering superinfections and antimicrobial resistance during COVID-19]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/considering-superinfections-and-antimicrobial-resistance-during-covid-19</link><description><![CDATA[  Joey Sweeney, PharmD, BCPS  

   

 Superinfections—infections that occur alongside another infection—are often present in patients who have died from COVID-19. Patients with COVID-19 who ...]]></description><pubDate>Tue, 07 Jul 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/considering-superinfections-and-antimicrobial-resistance-during-covid-19</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2811]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[ISMP updates: Remdesivir, propofol, and vincristine]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/ismp-updates-remdesivir-propofol-and-vincristine</link><description><![CDATA[  Maria G. Tanzi, PharmD  

 Over the past few months the Institute for Safe Medication Practices (ISMP) has released information on a compounding error that occurred with the investigational use ...]]></description><pubDate>Tue, 07 Jul 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/ismp-updates-remdesivir-propofol-and-vincristine</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2812]]></dc:identifier></item></channel></rss>